A natural compound steps into the estrogen arena

Uterine fibroids and endometriosis are 2 of the astir communal gynecologic diseases, affecting 15% to 80% of women of childbearing age. Existing treatments—hormonal drugs and selective estrogen receptor modulators—have broadside effects and cannot reliably forestall recurrence. This is wherefore little harmful non-hormonal therapies are urgently needed.